Legato Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$716K Buy
+180,409
New +$753K 0.06% 460
2026
Q2
– Sell
-156,059
Closed -$548K – 770
2026
Q1
$548K Buy
+156,059
New +$640K 0.05% 520

Other funds holding IRWD

Legato Capital Management's IRWD Position: Q3 2026 in Review

Legato Capital Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q3 2026: 180,409 shares worth $716K. The stake represents 0.06% of the portfolio and ranks #460 among its holdings. This is a return to the name: Legato Capital Management previously reported a position in IRWD as recently as Q1 2026.

Legato Capital Management first reported a position in IRWD in Q1 2026 and has held it in 2 quarters since. 234 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Legato Capital Management held 180,409 shares of Ironwood Pharmaceuticals worth $716K as of Q3 2026.
  • Ironwood Pharmaceuticals was a new Legato Capital Management position in Q3 2026.
  • Ironwood Pharmaceuticals made up 0.06% of Legato Capital Management's portfolio in Q3 2026, its #460 holding.
  • Legato Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 234 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Legato Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.